Detalles de la búsqueda
1.
Neutralizing Antibody Activity to Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) and Omicron (B.1.1.529) After 1 or 2 Doses of BNT162b2 Vaccine in Infection-Naive and Previously Infected Individuals.
J Infect Dis
; 226(8): 1407-1411, 2022 10 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35759252
2.
Longitudinal Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Antibody Responses and Identification of Vaccine Breakthrough Infections Among Healthcare Workers Using Nucleocapsid Immunoglobulin G.
J Infect Dis
; 226(11): 1934-1942, 2022 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36263799
3.
Effects of a booster dose of BNT162b2 on spike-binding antibodies to SARS-CoV-2 Omicron BA.2, BA.3, BA.4 and BA.5 subvariants in infection-naïve and previously-infected individuals.
Vaccine
; 41(4): 879-882, 2023 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36572601
4.
Detection of SARS-CoV-2 antibodies after confirmed Omicron BA.1 and presumed BA.4/5 infections using Abbott ARCHITECT and Panbio assays.
IJID Reg
; 7: 277-280, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37234563
Resultados
1 -
4
de 4
1
Próxima >
>>